Fibrilación auricular no valvular en pacientes en hemodiálisis crónica. ¿Debemos anticoagular?

Fibrilación auricular no valvular en pacientes en hemodiálisis crónica. ¿Debemos anticoagular?

Resumen: La enfermedad renal crónica (ERC) es un factor de riesgo independiente para presentar fibrilación auricular (FA) lo que condiciona un incremento del riesgo ya presente en la ERC de sufrir un evento tromboembólico; y este riesgo es mayor aún en la población en hemodiálisis (HD). Por otro lad...

Full description

Bibliographic Details
Main Authors:	Carmen Sánchez-González, Jose Antonio Herrero Calvo
Format:	Article
Language:	Spanish
Published:	Elsevier 2022-11-01
Series:	Nefrología
Subjects:	Atrial fibrillation Haemodialysis Oral anticoagulation Vitamin K antagonists Direct acting oral anticoagulants Oral anticoagulant therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S021169952200011X

Similar Items

Fibrilación auricular no valvular en pacientes en diálisis peritoneal: prevalencia, tratamiento y profesionales implicados
by: Elisa Perez-Bernat, et al.
Published: (2024-03-01)

Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA‐AF Phase III Registry
by: Valentina Bayer, et al.
Published: (2022-03-01)

Current strategies to improve the efficiency and safety of prevention and treatment of embolic stroke in non-valvular atrial fibrillation: possibilities of neutralizing therapy
by: S. N. Yanishevsky
Published: (2018-11-01)

Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation: A Population‐Based Cohort Study
by: Woldesellassie M. Bezabhe, et al.
Published: (2022-04-01)

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
by: Gilda Denise Zielinski, et al.
Published: (2020-01-01)

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
by: Iwona Gorczyca, et al.
Published: (2020-11-01)

Stroke prevention for non-valvular atrial fibrillation: how to make the right choice of directly acting oral anticoagulants?
by: N. N. Kryukov, et al.
Published: (2019-02-01)

Novel oral anticoagulants in primary care in patients with atrial fibrillation: a cross-sectional comparison before and after their introduction
by: Simon Schwill, et al.
Published: (2018-07-01)

Non-Vitamin K Oral Anticoagulants Assessment in High Risk of Bleeding Patients with Non-Valvular Atrial Fibrillation
by: Pedro Silva Cunha, et al.
Published: (2022-02-01)

THE APPROPRIATENESS OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE
by: A. Y. RYCHKOV, et al.
Published: (2016-12-01)

GLOBAL CLINICAL PRACTICE AND PERSONALIZED CHOICES FOR ORAL ANTICOAGULANT THERAPY FOR NON-VALVULAR ATRIAL FIBRILLATION
by: A. V. Fonyakin, et al.
Published: (2016-12-01)

Oral anticoagulation – current knowlegde
by: Anna Karaś, et al.
Published: (2022-10-01)

Effects of the availability of new oral anticoagulants in patients with non-valvular atrial fibrillation in the real world: the NAIF study
by: Francesco Ventrella, et al.
Published: (2016-07-01)

Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era
by: Ojasav Sehrawat, et al.
Published: (2023-06-01)

Oral Anticoagulants Preference in Hospitalized Patients with Acute Deep Vein Thrombosis or Non-Valvular Atrial Fibrillation
by: Ştefan Cristian Vesa, et al.
Published: (2020-10-01)

Analysis of Adverse Events in the Treatment of Patients with Non-Valvular Atrial Fibrillation with Oral Anticoagulants: Data from the “ANTEY” Observational Study
by: Sergey Yu. Martsevich, et al.
Published: (2022-09-01)

Comentarios a «Fibrilación auricular no valvular en pacientes en hemodiálisis crónica. ¿Debemos anticoagular?»
by: Aleix Cases, et al.
Published: (2023-01-01)

Central American and Caribbean Consensus Document for the Optimal Management of Oral Anticoagulation in Patients with Non-Valvular Atrial Fibrillation Endorsed by the Central American and Caribbean Society of Arterial Hypertension and Cardiovascular Prevention
by: Fernando Wyss, et al.
Published: (2024-01-01)

Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry
by: Anna Szpotowicz, et al.
Published: (2021-10-01)

Risk Profiles of New Users of Oral Anticoagulants Between 2011 and 2019 in Germany
by: Voss A, et al.
Published: (2023-07-01)

Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy
by: S. N. Yanishevsky
Published: (2019-06-01)

Apixaban
by: Gianluca Airoldi, et al.
Published: (2013-03-01)

Management and Prognosis of Acute Stroke in Atrial Fibrillation
by: Mette F. Hindsholm, et al.
Published: (2023-09-01)

Oral anticoagulant therapy for older patients with atrial fibrillation
by: Mario Bo, et al.
Published: (2017-09-01)

Clinical outcomes and anticoagulation therapy in elderly non‐valvular atrial fibrillation and heart failure patients
by: Shota Ikeda, et al.
Published: (2024-04-01)

Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice
by: Yu. P. Skirdenko, et al.
Published: (2022-03-01)

Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation
by: Sabine F. B. van der Horst, et al.
Published: (2023-07-01)

Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01)

Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines‐Atrial Fibrillation
by: Frederik Dalgaard, et al.
Published: (2020-12-01)

Non‑persistence to Oral Anticoagulation Therapy in Elderly Patients with Non‑valvular Atrial Fibrillation
by: Cao Y, et al.
Published: (2023-12-01)

2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
by: Chern-En Chiang, MD, PhD, et al.
Published: (2017-08-01)

Oral Anticoagulants after Heart Transplantation—Comparison between Vitamin K Antagonists and Direct Oral Anticoagulants
by: Fabrice F. Darche, et al.
Published: (2023-06-01)

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
by: Alfredo Caturano, et al.
Published: (2019-09-01)

PRACTICAL CONCERNS OF ANTICOAGULATION IN NONVALVULAR ATRIAL FIBRILLATION: A UNIVERSITY CLINICS REGISTRY
by: A. A. Sokolova, et al.
Published: (2015-09-01)

Contribution of anticoagulant therapy adherence to the risk of complications of atrial fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2019-03-01)

Retrospective Comparison of Patients ≥ 80 Years With Atrial Fibrillation Prescribed Either an FDA-Approved Reduced or Full Dose Direct-Acting Oral Anticoagulant
by: Roy Taoutel, et al.
Published: (2022-12-01)

Efficacy and safety of anticoagulation in atrial fibrillation patients with intracranial hemorrhage: A systematic review and meta-analysis
by: Qiang Zhou, et al.
Published: (2023-03-01)

Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up
by: Monika Kozieł, et al.
Published: (2020-06-01)

Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation – real-life data from a survey in Eastern Switzerland
by: Micha T. Maeder, et al.
Published: (2017-10-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01)